Next Level Wealth Planning’s Pulse Biosciences PLSE Stock Holding History

Next Level Wealth Planning’s Portfolio PLSE Stock Details PLSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$3.49K	Buy	+70	New	+$2.95K	﹤0.01%	415

Other funds holding PLSE

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Griffin Asset Management New York $934M AUM 18.69% 1-Year Est. Return

Westside Investment Management Santa Monica, California $785M AUM 29.89% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Inspire Investing Meridian, Idaho $2.37B AUM 29.82% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

Next Level Wealth Planning's PLSE Position: Q3 2026 in Review

Next Level Wealth Planning opened a new position in Pulse Biosciences (PLSE) in Q3 2026: 70 shares worth $3.49K. The stake represents ﹤0.01% of the portfolio and ranks #415 among its holdings.

46 funds tracked by Wall St. Rank hold PLSE as of Q3 2026.

Next Level Wealth Planning held 70 shares of Pulse Biosciences worth $3.49K as of Q3 2026.
Pulse Biosciences was a new Next Level Wealth Planning position in Q3 2026.
Pulse Biosciences made up ﹤0.01% of Next Level Wealth Planning's portfolio in Q3 2026, its #415 holding.
46 funds tracked by Wall St. Rank held Pulse Biosciences as of Q3 2026.

Based on Next Level Wealth Planning's 13F filing for Q3 2026, filed 29 Oct 2026.